1.           Introduction

1.1       The Insight Partners Research Report Guidance

1.2       Market Segmentation

2.           Executive Summary

2.1       Key Insights

3.           Research Methodology

3.1       Secondary Research

3.2       Primary Research

3.2.1         Hypothesis formulation:

3.2.2         Macro-economic factor analysis:

3.2.3         Developing base number:

3.2.4         Data Triangulation:

3.2.5         Country level data:

4.           Middle East & Africa Genotyping Market Landscape

4.1       Overview

4.2       Global Market Share Analysis

4.2.1         Global Market Share (%) of Leading Players for NGS Library Preparation

4.2.2         Global Market Share (%) of Leading Player for Genotyping

4.2.3         Global Market Share (%) of Leading Player for Gene Expression

5.           Middle East & Africa Genotyping Market – Key Market Dynamics

5.1       Market Drivers:

5.1.1         Use in Diagnosis of Genetic and Rare Diseases

5.1.2         Technological Advancements and Rising R&D Investments in Biotechnology and Pharmaceutical Industry

5.2       Market Restraints

5.2.1         High Cost of Equipment and Shortage of Skilled Professionals

5.3       Market Opportunities

5.3.1         Expanding Range of Applications

5.4       Future Trends

5.4.1         Increasing Popularity of Personalized Medicine

5.5       Impact of Drivers and Restraints:

6.           Genotyping Market – Middle East & Africa Analysis

6.1       Genotyping Market Revenue (US$ Million), 2021–2031

7.           Middle East & Africa Genotyping Market Analysis – by Product Type

7.1       Instruments

7.1.1         Overview

7.1.2         Instruments: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)

7.2       Reagents and Kits

7.2.1         Overview

7.2.2         Reagents and Kits: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)

7.3       Bioinformatics

7.3.1         Overview

7.3.2         Bioinformatics: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)

7.4       Genotyping Services

7.4.1         Overview

7.4.2         Genotyping Services: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)

8.           Middle East & Africa Genotyping Market Analysis – by Technology

8.1       Microarray

8.1.1         Overview

8.1.2         Microarray: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)

8.2       Capillary Electrophoresis

8.2.1         Overview

8.2.2         Capillary Electrophoresis: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)

8.3       Sequencing

8.3.1         Overview

8.3.2         Sequencing: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)

8.4       Polymerase Chain Reaction (PCR)

8.4.1         Overview

8.4.2         Polymerase Chain Reaction (PCR): Genotyping Market – Revenue and Forecast to 2031 (US$ Million)

8.5       Matrix-Assisted Laser Desorption / MALDI-TOF

8.5.1         Overview

8.5.2         Matrix-Assisted Laser Desorption / MALDI-TOF: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)

8.6       Other Technologies

8.6.1         Overview

8.6.2         Other Technologies: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)

9.           Middle East & Africa Genotyping Market Analysis – by Application

9.1       Pharmacogenomics

9.1.1         Overview

9.1.2         Pharmacogenomics: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)

9.2       Diagnostics and Personalized Medicine

9.2.1         Overview

9.2.2         Diagnostics and Personalized Medicine: Genotyping Market – Revenue and Forecast to 2031  (US$ Million)

9.3       Animal Genetics

9.3.1         Overview

9.3.2         Animal Genetics: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)

9.4       Agricultural Biotechnology

9.4.1         Overview

9.4.2         Agricultural Biotechnology: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)

9.5       Other Applications

9.5.1         Overview

9.5.2         Other Applications: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)

10.        Middle East & Africa Genotyping Market Analysis – by End-user

10.1     Pharmaceutical and Biopharmaceutical Companies

10.1.1       Overview

10.1.2       Pharmaceutical and Biopharmaceutical Companies: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)

10.2     Diagnostic and Research Laboratories

10.2.1       Overview

10.2.2       Diagnostic and Research Laboratories: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)

10.3     Academic Institutes

10.3.1       Overview

10.3.2       Academic Institutes: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)

10.4     Other End Users

10.4.1       Overview

10.4.2       Other End Users: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)

11.        Middle East & Africa Genotyping Market – Country Analysis

11.1     Middle East & Africa

11.1.1       Middle East & Africa: Genotyping Market – Revenue and Forecast Analysis – by Country

11.1.1.1          Saudi Arabia: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)

11.1.1.1.1        Saudi Arabia: Genotyping Market Breakdown, by Product Type

11.1.1.1.2        Saudi Arabia: Genotyping Market Breakdown, by Technology

11.1.1.1.3        Saudi Arabia: Genotyping Market Breakdown, by Application

11.1.1.1.4        Saudi Arabia: Genotyping Market Breakdown, by End-user

11.1.1.2          South Africa: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)

11.1.1.2.1        South Africa: Genotyping Market Breakdown, by Product Type

11.1.1.2.2        South Africa: Genotyping Market Breakdown, by Technology

11.1.1.2.3        South Africa: Genotyping Market Breakdown, by Application

11.1.1.2.4        South Africa: Genotyping Market Breakdown, by End-user

11.1.1.3          United Arab Emirates: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)

11.1.1.3.1        United Arab Emirates: Genotyping Market Breakdown, by Product Type

11.1.1.3.2        United Arab Emirates: Genotyping Market Breakdown, by Technology

11.1.1.3.3        United Arab Emirates: Genotyping Market Breakdown, by Application

11.1.1.3.4        United Arab Emirates: Genotyping Market Breakdown, by End-user

11.1.1.4          Rest of Middle East & Africa: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)

11.1.1.4.1        Rest of Middle East & Africa: Genotyping Market Breakdown, by Product Type

11.1.1.4.2        Rest of Middle East & Africa: Genotyping Market Breakdown, by Technology

11.1.1.4.3        Rest of Middle East & Africa: Genotyping Market Breakdown, by Application

11.1.1.4.4        Rest of Middle East & Africa: Genotyping Market Breakdown, by End-user

12.        Industry Landscape

12.1     Overview

12.2     Growth Strategies in Genotyping Market

12.3     Organic Growth Strategies

12.3.1       Overview

12.4     Inorganic Growth Strategies

12.4.1       Overview

13.        Company Profiles

13.1     Hoffmann-La Roche Ltd

13.1.1       Key Facts

13.1.2       Business Description

13.1.3       Products and Services

13.1.4       Financial Overview

13.1.5       SWOT Analysis

13.1.6       Key Developments

13.2     QIAGEN NV

13.2.1       Key Facts

13.2.2       Business Description

13.2.3       Products and Services

13.2.4       Financial Overview

13.2.5       SWOT Analysis

13.2.6       Key Developments

13.3     Merck KGaA

13.3.1       Key Facts

13.3.2       Business Description

13.3.3       Products and Services

13.3.4       Financial Overview

13.3.5       SWOT Analysis

13.3.6       Key Developments

13.4     Thermo Fisher Scientific Inc

13.4.1       Key Facts

13.4.2       Business Description

13.4.3       Products and Services

13.4.4       Financial Overview

13.4.5       SWOT Analysis

13.4.6       Key Developments

13.5     BioTek Instruments, Inc.

13.5.1       Key Facts

13.5.2       Business Description

13.5.3       Products and Services

13.5.4       Financial Overview

13.5.5       SWOT Analysis

13.5.6       Key Developments

13.6     Illumina Inc

13.6.1       Key Facts

13.6.2       Business Description

13.6.3       Products and Services

13.6.4       Financial Overview

13.6.5       SWOT Analysis

13.6.6       Key Developments

13.7     Danaher Corp

13.7.1       Key Facts

13.7.2       Business Description

13.7.3       Products and Services

13.7.4       Financial Overview

13.7.5       SWOT Analysis

13.7.6       Key Developments

13.8     Bio-Rad Laboratories Inc

13.8.1       Key Facts

13.8.2       Business Description

13.8.3       Products and Services

13.8.4       Financial Overview

13.8.5       SWOT Analysis

13.8.6       Key Developments

13.9     GE HealthCare Technologies Inc

13.9.1       Key Facts

13.9.2       Business Description

13.9.3       Products and Services

13.9.4       Financial Overview

13.9.5       SWOT Analysis

13.9.6       Key Developments

13.10  Standard BioTools Inc

13.10.1    Key Facts

13.10.2    Business Description

13.10.3    Products and Services

13.10.4    Financial Overview

13.10.5    SWOT Analysis

13.10.6    Key Developments

13.11  Laboratory Corp of America Holdings

13.11.1    Key Facts

13.11.2    Business Description

13.11.3    Products and Services

13.11.4    Financial Overview

13.11.5    SWOT Analysis

13.11.6    Key Developments

13.12  Beckman Coulter Inc

13.12.1    Key Facts

13.12.2    Business Description

13.12.3    Products and Services

13.12.4    Financial Overview

13.12.5    SWOT Analysis

13.12.6    Key Developments

13.13  BGI

13.13.1    Key Facts

13.13.2    Business Description

13.13.3    Products and Services

13.13.4    Financial Overview

13.13.5    SWOT Analysis

13.13.6    Key Developments

13.14  Takara Bio Inc

13.14.1    Key Facts

13.14.2    Business Description

13.14.3    Products and Services

13.14.4    Financial Overview

13.14.5    SWOT Analysis

13.14.6    Key Developments

13.15  DiaSorin SpA

13.15.1    Key Facts

13.15.2    Business Description

13.15.3    Products and Services

13.15.4    Financial Overview

13.15.5    SWOT Analysis

13.15.6    Key Developments

14.        Appendix

14.1     About Us

14.2     Glossary of Terms

List of Tables

Table 1.             Middle East & Africa Genotyping Market Segmentation

Table 2.             Genotyping Market – Revenue and Forecast to 2031 (US$ Million) – by Product Type

Table 3.             Genotyping Market – Revenue and Forecast to 2031 (US$ Million) – by Technology

Table 4.             Genotyping Market – Revenue and Forecast to 2031 (US$ Million) – by Application

Table 5.             Genotyping Market – Revenue and Forecast to 2031 (US$ Million) – by End-user

Table 6.             Saudi Arabia: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Product Type

Table 7.             Saudi Arabia: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Technology

Table 8.             Saudi Arabia: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 9.             Saudi Arabia: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by End-user

Table 10.          South Africa: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Product Type

Table 11.          South Africa: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Technology

Table 12.          South Africa: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 13.          South Africa: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by End-user

Table 14.          United Arab Emirates: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Product Type

Table 15.          United Arab Emirates: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Technology

Table 16.          United Arab Emirates: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 17.          United Arab Emirates: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by End-user

Table 18.          Rest of Middle East & Africa: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Product Type

Table 19.          Rest of Middle East & Africa: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Technology

Table 20.          Rest of Middle East & Africa: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 21.          Rest of Middle East & Africa: Genotyping Market – Revenue and Forecast to 2031(US$ Million) – by End-user

Table 22.          Recent Organic Growth Strategies in Genotyping Market

Table 23.          Recent Inorganic Growth Strategies in the Genotyping Market

Table 24.          Glossary of Terms, Genotyping Market

List of Figures

Figure 1.           Middle East & Africa Genotyping Market Segmentation, by Country

Figure 2.           Genotyping Market – Key Market Dynamics

Figure 3.           Impact Analysis of Drivers and Restraints

Figure 4.           Genotyping Market Revenue (US$ Million), 2021–2031

Figure 5.           Genotyping Market Share (%) – by Product Type (2023 and 2031)

Figure 6.           Instruments: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)

Figure 7.           Reagents and Kits: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)

Figure 8.           Bioinformatics: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)

Figure 9.           Genotyping Services: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)

Figure 10.        Genotyping Market Share (%) – by Technology (2023 and 2031)

Figure 11.        Microarray: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)

Figure 12.        Capillary Electrophoresis: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)

Figure 13.        Sequencing: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)

Figure 14.        Polymerase Chain Reaction (PCR): Genotyping Market – Revenue and Forecast to 2031 (US$ Million)

Figure 15.        Matrix-Assisted Laser Desorption / MALDI-TOF: Genotyping Market – Revenue and Forecast to 2031  (US$ Million)

Figure 16.        Other Technologies: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)

Figure 17.        Genotyping Market Share (%) – by Application (2023 and 2031)

Figure 18.        Pharmacogenomics: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)

Figure 19.        Diagnostics and Personalized Medicine: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)

Figure 20.        Animal Genetics: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)

Figure 21.        Agricultural Biotechnology: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)

Figure 22.        Other Applications: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)

Figure 23.        Genotyping Market Share (%) – by End-user (2023 and 2031)

Figure 24.        Pharmaceutical and Biopharmaceutical Companies: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)

Figure 25.        Diagnostic and Research Laboratories: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)

Figure 26.        Academic Institutes: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)

Figure 27.        Other End Users: Genotyping Market – Revenue and Forecast to 2031 (US$ Million)

Figure 28.        Middle East & Africa Genotyping Market, by Key Countries - Revenue (2023) (US$ Million)

Figure 29.        Middle East & Africa: Genotyping Market Breakdown, by Key Countries, 2023 and 2031 (%)

Figure 30.        Saudi Arabia: Genotyping Market – Revenue and Forecast to 2031(US$ Million)

Figure 31.        South Africa: Genotyping Market – Revenue and Forecast to 2031(US$ Million)

Figure 32.        United Arab Emirates: Genotyping Market – Revenue and Forecast to 2031(US$ Million)

Figure 33.        Rest of Middle East & Africa: Genotyping Market – Revenue and Forecast to 2031(US$ Million)

Figure 34.        Growth Strategies in Genotyping Market